Pmv Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Pmv Pharmaceuticals
PMVP Stock  USD 1.27  0.01  0.79%   
Pmv Pharmaceuticals financial statements provide useful quarterly and yearly information to potential Pmv Pharmaceuticals investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Pmv Pharmaceuticals financial statements helps investors assess Pmv Pharmaceuticals' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Pmv Pharmaceuticals' valuation are summarized below:
Market Capitalization
65.4 M
Earnings Share
(1.14)
There are currently one hundred twenty trending fundamental ratios for Pmv Pharmaceuticals that can be evaluated and compared over time across competitors. Investors and active traders are advised to check out Pmv Pharmaceuticals' recent fundamental performance against the performance between 2010 and 2025 to make sure the trends are evolving in the right direction. As of 03/19/2025, Market Cap is likely to drop to about 85.1 M. In addition to that, Enterprise Value is likely to drop to about 41.7 M
Check Pmv Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pmv Pharmaceuticals' main balance sheet or income statement drivers, such as Net Interest Income of 11.2 M, Interest Income of 11.2 M or Depreciation And Amortization of 1.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.46. Pmv financial statements analysis is a perfect complement when working with Pmv Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Pmv Pharmaceuticals Correlation against competitors.
To learn how to invest in Pmv Stock, please use our How to Invest in Pmv Pharmaceuticals guide.

Pmv Pharmaceuticals Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets247.9 M191.3 M145.8 M
Slightly volatile
Other Current Liabilities6.3 M7.4 M3.5 M
Slightly volatile
Total Current Liabilities10.2 M14.4 M5.8 M
Slightly volatile
Other Liabilities51.7 K58.6 K47 K
Slightly volatile
Property Plant And Equipment Net1.5 M1.6 M4.1 M
Slightly volatile
Accounts Payable3.4 M6.6 M2.1 M
Slightly volatile
Cash38.8 M40.9 M69.1 M
Slightly volatile
Non Current Assets Total18.4 M15.6 M9.1 M
Slightly volatile
Non Currrent Assets Other14.8 M14.1 M2 M
Slightly volatile
Other Assets0.860.9171.6 K
Slightly volatile
Cash And Short Term Investments225.6 M169.5 M134.8 M
Slightly volatile
Common Stock Shares Outstanding48.6 M51.6 M38 M
Slightly volatile
Liabilities And Stockholders Equity247.9 M191.3 M145.8 M
Slightly volatile
Non Current Liabilities Total796.1 K838 K73.4 M
Slightly volatile
Other Current Assets4.4 M6.2 M2.2 M
Slightly volatile
Other Stockholder Equity396.3 M544.7 M184.4 M
Slightly volatile
Total Liabilities14.4 M15.2 M79.4 M
Slightly volatile
Property Plant And Equipment Gross2.9 M3 M4.5 M
Slightly volatile
Total Current Assets229.5 M175.7 M136.7 M
Slightly volatile
Non Current Liabilities Other16.2 M15.5 M5 M
Slightly volatile
Net Working Capital219.3 M161.3 M130.9 M
Slightly volatile
Property Plant Equipment13.2 M12.6 M4.5 M
Slightly volatile
Short and Long Term Debt Total1.1 M1.2 M108.8 M
Slightly volatile
Capital Surpluse525.4 M560.6 M481 M
Slightly volatile
Short Term Debt613.2 K352 K784.1 K
Slightly volatile
Current Deferred Revenue73.6 K82.8 K90.3 K
Slightly volatile

Pmv Pharmaceuticals Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Net Interest Income11.2 M10.7 M3.1 M
Slightly volatile
Interest Income11.2 M10.7 M3.1 M
Slightly volatile
Depreciation And Amortization1.5 M1.4 M536.9 K
Slightly volatile
Selling General Administrative18.8 M26.9 M11.2 M
Slightly volatile
Other Operating Expenses54.3 M92.2 M37.1 M
Slightly volatile
Research Development40.9 M58.5 M25.7 M
Slightly volatile
Total Operating Expenses59.9 M85.4 M37 M
Slightly volatile
Reconciled Depreciation594.5 K1.1 M442.6 K
Slightly volatile
Total Other Income Expense Net11.2 M10.6 M2.4 M
Slightly volatile
Cost Of Revenue856.7 K1.4 M605.5 K
Slightly volatile
Non Operating Income Net Other4.5 M4.3 M1.4 M
Slightly volatile
Selling And Marketing Expenses19.4 M21.8 M23.8 M
Slightly volatile

Pmv Pharmaceuticals Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.4 M8.9 M3.5 M
Slightly volatile
Begin Period Cash Flow36.6 M38.5 M64.8 M
Slightly volatile
Depreciation639.1 K1.1 M463.1 K
Slightly volatile
Capital Expenditures622.2 K655 K993.6 K
Slightly volatile
Total Cash From Financing Activities297.4 K313 K59.4 M
Pretty Stable
End Period Cash Flow38.8 M40.9 M69.3 M
Slightly volatile
Change To Netincome12.2 M11.6 M4.2 M
Slightly volatile
Sale Purchase Of Stock819.1 K862.2 K201.8 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation0.540.57262.775
Pretty Stable
Payables Turnover0.220.350.3026
Pretty Stable
Cash Per Share3.633.28533.2053
Slightly volatile
Days Payables Outstanding1.7 K1.1 K1.3 K
Pretty Stable
Income Quality0.950.87350.8697
Pretty Stable
Current Ratio11.6112.223925.3921
Slightly volatile
Capex Per Share0.01210.01270.0241
Pretty Stable
Interest Debt Per Share0.02190.02312.2469
Slightly volatile
Debt To Assets0.00590.00621.0645
Slightly volatile
Days Of Payables Outstanding1.7 K1.1 K1.3 K
Pretty Stable
Ebt Per Ebit1.020.87550.9369
Pretty Stable
Long Term Debt To Capitalization0.00380.00430.0046
Slightly volatile
Total Debt To Capitalization0.00640.00671.1066
Slightly volatile
Quick Ratio11.6112.223925.3921
Slightly volatile
Net Income Per E B T1.070.78480.9911
Pretty Stable
Cash Ratio2.72.844513.8842
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.821.01281.0176
Slightly volatile
Debt Ratio0.00590.00621.0645
Slightly volatile

Pmv Pharmaceuticals Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap85.1 M89.6 M1 B
Slightly volatile
Enterprise Value41.7 M43.9 M1 B
Slightly volatile

Pmv Fundamental Market Drivers

Cash And Short Term Investments169.5 M

Pmv Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Pmv Pharmaceuticals Financial Statements

Pmv Pharmaceuticals shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Pmv Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in Pmv Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pmv Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue82.8 K73.6 K
Cost Of Revenue1.4 M856.7 K

Additional Tools for Pmv Stock Analysis

When running Pmv Pharmaceuticals' price analysis, check to measure Pmv Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pmv Pharmaceuticals is operating at the current time. Most of Pmv Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Pmv Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pmv Pharmaceuticals' price. Additionally, you may evaluate how the addition of Pmv Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY